Belviq Weight-Loss Drug Has Been Recalled Due to Cancer Risk

anoop kBelviq

On February 13, 2020, The U.S. Food and Drug Administration (FDA) requested that Japanese pharmaceutical company Eisai remove its weight-loss drugs Belviq and Belviq XR from the market due to findings from a clinical trial showing that long-term use of Belviq was associated with cancer.   The FDA has warned …